INFATRINI - Volantino


 
I dettagli della droga non sono disponibili nella lingua selezionata, viene visualizzato il testo originale
Generico: pzlu
Principio attivo:
Gruppo ATC: V06XX - pzlu
Contenuto di sostanza attiva:
imballaggio: Bottle


10273648
DSN expects that this PDF will be checked completely
regarding all text, lay-out, cutter, product code and bar-
code. If no correction is com-municated about any of
these items, DSN will consi-der this as being approved
for further processing and ultimately printing. Due to li-
mitations of digital proofingthis PDF cannot be seen as a
final printing result.
Questions? We are at your service.
De Schutter'Neroc nvBlancefloerlaan 179a
2050 AntwerpBelgium
For strong results visit
Telephone:
E-mail: info@ds-n.com
www.ds-n.com
Check printed size by aligning a ruler along this ruler.E.g.: When your ruler measures the printed ruler as 75 mm, this
means that this document was printed on 75%.
Check
ou

website!
Separations
First Barcode Number2D Code Numbe

Barcode BWR (μm)
1027364810273648
135,00Sign off operator:
Date approval:
Sign off DSN:
Sign off customer:
Job NameDSN Code
DescriptionAccount
Account Executive MailP
Previous Pack CodeCorporate Codeack Code
Artwork LoopRepro Loop
PacktypePrinte

Technical Plan
Printing ProcessUnwind DirectionDate
TimeHeight (mm)
Width (mm)Ink Coverage (%)
Profile NumberProof Profile
ZCBV905601_RE.apZCBV905601
160022CM Infatrini For infants 24 x 125 ml DE, PT, PL, GR, CZ, SK - PREPRINTDANONE TRADING BV
marc.vanderstraeten@ds-n.com10273648
10207187590574
31
OUTERCASETHIMM VERPACKUNG NORTHEIM GMBH + CO. KG
ZTM016_Outer case_ 24x125ml_ v02
Flexo***5/3:55 PM+672.
+425.270,00%
PR0001949THIMM DE F CMYK 09NOV06
+323 222 38 00Material Code***
This file was specifically produced for:
ZCBV905601_RE.ap/5/9/16 3:55 PM/PANTONE 268 C/Keyline/
8V=+672.H=+425.


Infatrini

Letak nebyl nalezen
Prodotti simili o alternativi
 
disponibile | Spedizione da 29 CZK
2 389 CZK

Informazioni sul progetto

Un progetto non commerciale liberamente disponibile ai fini dei confronti tra farmaci laici a livello di interazioni, effetti collaterali e prezzi dei farmaci e loro alternative

Ulteriori informazioni